Research validated by Valeo Health Experts
Our research is backed by clinical validation and solid evidence. Dive into our studies to discover the outcomes and the scientific principles that underpin our care model.
Research validated by Valeo Health Experts
Our research is backed by clinical validation and solid evidence. Dive into our studies to discover the outcomes and the scientific principles that underpin our care model.
Key Results
Down from 19.1% in 2022 across 28,904 UAE clients tested 2021–2026
Down from 7.20 mg/L in 2022, falling consistently year over year with no reversals
Latest releases
Biomarker Trends and Health Burden in UAE Residents: A Five-Year Longitudinal Analysis of 28,904 Clients (2021–2026)
Population-level biomarker data from real-world UAE clinical settings is scarce. This longitudinal analysis of 28,904 clients tested in Dubai (2021–2026), including 10,128 with repeat tests, found vitamin D deficiency in 43.2%, elevated total cholesterol in 42.8% and iron abnormality in 27.0% of women. HbA1c abnormality fell from 19.1% to 10.2%, coinciding with UAE GLP-1 adoption.
Key findings :The State of Emirati Women's Health: A Five-Year Biomarker Trends Report (2022–2026)
Published for Emirati Women's Day, this descriptive report tracks five years of preventive testing among Emirati women. Volume grew nearly twenty-fold, from 344 women in 2022 to 7,454 in 2025, as average age fell from 40.5 to 38.4. hs-CRP fell 72% and homocysteine 45%, while fasting insulin rose 42% and vitamin D averages stayed insufficient every year.
Key findings :Biomarker Trends and Health Burden in UAE Residents: A Five-Year Longitudinal Analysis of 28,904 Clients (2021–2026)
Population-level biomarker data from real-world UAE clinical settings is scarce. This longitudinal analysis of 28,904 clients tested in Dubai (2021–2026), including 10,128 with repeat tests, found vitamin D deficiency in 43.2%, elevated total cholesterol in 42.8% and iron abnormality in 27.0% of women. HbA1c abnormality fell from 19.1% to 10.2%, coinciding with UAE GLP-1 adoption.
Key findings :The State of Emirati Women's Health: A Five-Year Biomarker Trends Report (2022–2026)
Published for Emirati Women's Day, this descriptive report tracks five years of preventive testing among Emirati women. Volume grew nearly twenty-fold, from 344 women in 2022 to 7,454 in 2025, as average age fell from 40.5 to 38.4. hs-CRP fell 72% and homocysteine 45%, while fasting insulin rose 42% and vitamin D averages stayed insufficient every year.
Key findings :From PCOS to PMOS: Reframing a Common Female Endocrine Disorder in the GCC
PCOS — renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) by global consensus in 2026 — affects up to 30% of infertile women in the GCC. This retrospective analysis of 176 orders from 166 UAE female patients (2022–2026) across 11 biomarkers found FT4 the strongest temporal signal (ρ = +0.49), independent of age, alongside falling LH and the classical SHBG–insulin inverse link.
Key findings :The Expat Health Paradox: How Nationality Shapes Biomarker Risk in the UAE
No study has compared biomarker profiles across a large multi-nationality UAE cohort. This analysis of 14,302 clients across 27 nationalities (2022–2026) found significant between-group differences in six of twelve biomarkers. South Asian clients carried the heaviest cardiometabolic burden, Filipino clients the lowest vitamin D and highest CRP, and Emirati males an HbA1c of 9.47%.
Key findings :Preventive Health Monitoring and Biomarker Optimization in a Real-World Population (UAE & KSA)
Real-world data on longitudinal biomarker change outside clinical trials is limited in the MENA region. This observational study tracked 1,012 UAE and KSA adults completing at least two assessments in 2025, across 40,000+ measurements. Improvement was greatest in CRP (60% of participants) and fasting insulin (55%), with vitamin D improving in 57%, ferritin 55%, LDL-C 47% and HbA1c 41%.
Key findings :The State of Emirati Women's Health: A Five-Year Biomarker Trends Report (2022–2026)
Published for Emirati Women's Day, this descriptive report tracks five years of preventive testing among Emirati women. Volume grew nearly twenty-fold, from 344 women in 2022 to 7,454 in 2025, as average age fell from 40.5 to 38.4. hs-CRP fell 72% and homocysteine 45%, while fasting insulin rose 42% and vitamin D averages stayed insufficient every year.
Key findings :Biomarker Trends and Health Burden in UAE Residents: A Five-Year Longitudinal Analysis of 28,904 Clients (2021–2026)
Population-level biomarker data from real-world UAE clinical settings is scarce. This longitudinal analysis of 28,904 clients tested in Dubai (2021–2026), including 10,128 with repeat tests, found vitamin D deficiency in 43.2%, elevated total cholesterol in 42.8% and iron abnormality in 27.0% of women. HbA1c abnormality fell from 19.1% to 10.2%, coinciding with UAE GLP-1 adoption.
Key findings :